MELANOMA IHC PANEL

What this test checks

A combined panel of immunohistochemistry markers (S100, Melan-A, HMB45, SOX10 etc.) specifically designed to confirm melanoma diagnosis and differentiate it from other tumour types.

Why do people get this test?

Melanoma can mimic many other tumours histologically. A dedicated melanoma panel provides definitive confirmation — essential before starting immunotherapy (checkpoint inhibitors) or BRAF-targeted therapy, which are specific to melanoma.

When you should consider this test

• When melanoma diagnosis needs confirmation
• When an undifferentiated tumour might be melanoma
• Before starting melanoma-specific targeted therapy or immunotherapy

How to prepare

No preparation needed — performed on biopsy or surgical tissue.